Navigation Links
Gene chip data improved therapy in some patients with incurable cancer
Date:9/19/2007

ATLANTA Like many oncologists, Eric P. Lester, M.D., was faced with a dilemma: seven patients with advanced, incurable cancer, an arsenal of drugs that may or may not help them, and not enough solid proof about treatment efficacy to guide him. So Dr. Lester devised what he called a simple-minded experiment that illustrates the promise of personalized medicine. Using DNA microarray chips, Dr. Lester analyzed his patients tumors for expression of genes associated with good response to various anti-cancer drugs, and based his drug treatment plans on the results. Four out of seven patients with advanced cancer enrolled in the extremely limited study had a better outcome than expected.

The finding, presented today in Atlanta, Ga. at the American Association for Cancer Researchs second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, shows that a personalized molecular oncology approach, basing chemotherapy on relative gene expression in tumors, holds promise even at the relatively crude level employed here, said study investigator, Dr. Lester, president of Oncology Care Associates in St. Joseph, Mich.

To obtain and analyze chip data, Dr. Lester worked with Craig Webb, Ph.D., Director of Translational Medicine at the Van Andel Research Institute in Grand Rapids, Mich.

The study is unusual because oncologists dont yet base most of their treatment decisions on gene profiling, especially when it might involve pairing drugs together in a novel combination or using varied doses, Dr. Lester said. Much of clinical medicine is an educated guess, and this was an attempt to come up with a better approach by using the technology of a gene chip to make multiple, highly educated guesses simultaneously, Dr. Lester said.

Dr. Lester added that one of the seven participating patients died before the gene chip was used to direct therapy.

Many current clinical trials involving gene expression examine eff
'/>"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Voice may be improved by surgery
2. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
3. ICU Survival can be improved by Antibiotic use
4. Survival rate not improved by invasive procedures
5. WHO report asks for improved healthcare for mother and child
6. Improved height from administration of growth hormones
7. Improved procedure to do laproscopic esophagectomy discovered
8. Novel antibiotic dressing developed for improved wound healing
9. Improved parent-physician communication to prevent hospitalizations for childhood asthma
10. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
11. Important parameters of life: Longevity and quality: both improved by exercise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...mosomal change that raises odds for malignancy, st... News) -- Some Japanese survivors of the World War...xperienced key genetic changes that may have spark...arch indicates. , Papillary thyroid cancer (PTC...tion involving the so-called BRAF gene. But Japane...
(Date:8/29/2008)...RNewswire/ -- In response to recent news,about Mic...isease (CWD),members of the deer farming communit...ing season fast approaching, the tragic incident r...County farm understandably has,created concern amo...cross,the great state of Michigan. The deer farmin...
(Date:8/29/2008)... to More Than 30 European Countries, HONOLULU, Au...d today,that it has successfully completed the int...ical Device Directive (for most European Union cou...rk -- or Conformite Europeene Mark,-- for the Life...na,s,patient safety reach to include more than 30 ...
(Date:8/29/2008)...presents Telemedicine Encounter Management Systems...ions as a possible solution to national health car...d, MA (PRWEB) August 29, 2008 -- If there has been...s at the Democratic National Convention it has bee...ional health care issues., , ,Our Democratic leade...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...ability to speak, communicate and relate to others...ence Autism Speaks, a non-profit organization has ... be created on autism. // It was founded in 2005.... between the patients, doctors, researchers and th...
... M.D., and colleagues say that mutation in CCR5 (c...nfection but increases the risk of developing West...NV) illness is caused due to a mosquito-borne viru...tional Institute of Allergy and Infectious Disease...
...ool in Scotland with the object of preventing chil.... Seminars are proposed to be conducted in schools...e reportedly resulting in the number of skin cance... Thomas Muir High School are reported to be going ...
...colleagues of the University of Texas Health Scien...he rat acts as an anti-depressant. Leptin is a hor...ulation. // The research was done on chronic unpre... that CUS rats had decreased levels of Leptin than...
Other Medicine News:Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2Health News:Leptin, The Next Generation Antidepressant? 2
(Date:8/25/2008)...Y HILLS, Mass., Aug. 25 /- Joseph F. ... of Spherics, Inc. ("Spherics") for,the benefit of...l,intellectual property will be sold at a sealed b...tended release formulation of Levodopa-Carbidopa t...kinson,s disease, with global,sales estimated at a...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...men Enrolled in Trial Sponsored by Medical Researc...FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nasda...lment in Protocol MDP 301, a Phase III clinical tr...icrobicide for the prevention of HIV and other,sex...ed by the United,Kingdom,s Medical Research Counci...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 1RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 22007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 12007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 2Rodent study finds artificial butter chemical harmful to lungs 14287 1Rodent study finds artificial butter chemical harmful to lungs 14287 2
...Maintained Improvement in Personal and Social,Pe...07 /PRNewswire/ --,Longer-term treatment with IN..., a new once daily oral medication for,schizophr...ir,symptoms and maintain their improvements in p... data are from a large, open label, international,...
...nforce Astellas Commitment to Overcoming Critical,...many, April 02, 2007 /PRNewswire/ --Study results,...l Microbiology,and Infectious Diseases (ECCMID) sh...gal micafungin, both have the potential,to meet a ...s,hospital-acquired infections (HAIs). , Hospital-...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
... System provides a unique option for the correctio...arly the opening wedge osteotomy of the first meta...mall Fragment Plate and Screw Set is a complete tr...es the plates, screws, and drills. It provides a m...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Medicine Products: